For the Inventor, By the Inventor

Enter assignee name

Hennigsdorf, Germany

Sphingotec Gmbh

USPTO Granted Patents = 21

CIPO Patents = 2

EPO Patents = 16

Trademarks = 6

Forward Citations = 74

Loading Chart...

Loading Chart...

4 inventors (with patents filed for the assignee):

Andreas Bergmann (20 out of 109 patents)

Olle Melander (6 out of 9 patents)

Andrea Ernst (4 out of 7 patents)

4. Harald Hampel (1 out of 4 patents)

5. Andrea Sparwasser (0 patent)

6. Adriaan Voors (0 patent)

7. Leong Ng (0 patent)

21 patents: Sort by Forward Citations

1. 12399186 - Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction (2025-08-26),

2. 12247988 - Adrenomedullin assays and methods for determining mature andrendomedullin (2025-03-11),

3. 12228581 - Adrenomedullin assays and methods for determining mature andrendomedullin (2025-02-18),

4. 11844812 - Selenoprotein P for prediction of a first cardiovascular event (2023-12-19),

5. 11726101 - Adrenomedullin assays and methods for determining mature adrenomedullin (2023-08-15),

6. 11598781 - Method for predicting the risk of incidence of chronic kidney disease (2023-03-07),

7. 11340240 - Method for predicting the risk of obesity in a subject (2022-05-24),

8. 11067586 - Adrenomedullin assays and methods for determining mature adrenomedullin (2021-07-20),

9. 11016107 - Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction (2021-05-25),

10. 10900978 - Method for predicting the risk of obesity in a subject (2021-01-26),

11. 10605812 - Method for predicting the risk of getting cancer or diagnosing cancer in a subject (2020-03-31),

12. 10598674 - Adrenomedullin to guide therapy of blood pressure decline (2020-03-24),

13. 10520512 - Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject (2019-12-31),

14. 10114029 - Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction (2018-10-30),

15. 9702876 - Method for predicting the risk of getting cancer or diagnosing cancer in a female subject (2017-07-11),

Sphingotec GmbH is a biotechnology company that specializes in the discovery, development, and commercialization of innovative biomarkers for diagnostic and therapeutic applications. With a focus on improving patient outcomes, Sphingotec's cutting-edge technologies enable healthcare professionals to identify and monitor critical diseases, such as sepsis, acute kidney injury, and congestive heart failure. By offering precise and rapid diagnostic solutions, Sphingotec aims to revolutionize personalized medicine and support healthcare systems worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#3 in Hennigsdorf

#2,154 in Germany

#29,076 in the World

Hennigsdorf, Germany

Sphingotec Gmbh

Forward Citations = 74

4 inventors:

Andreas Bergmann (20 out of 109 patents)

Olle Melander (6 out of 9 patents)

Andrea Ernst (4 out of 7 patents)

4. Harald Hampel (1 out of 4 patents)

5. Andrea Sparwasser (0 patent)

Please report any incorrect information to support@idiyas.com

Loading…